Sab Biotherapeutics Stock Forecast

Sell candidate since Jul 08, 2026 Gain 4.27%

The Sab Biotherapeutics, Inc. stock price gained 1.67% on the last trading day (Friday, 10th Jul 2026), rising from $0.0120 to $0.0122. During the last trading day the stock fluctuated 300.84% from a day low at $0.0119 to a day high of $0.0477. The price has risen in 5 of the last 10 days but is still down by -5.43% for this period. Volume fell on the last day by -118 thousand shares and in total, 161 thousand shares were bought and sold for approximately $1.96 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -45.14% during the next 3 months and, with a 90% probability hold a price between $0.0038 and $0.0089 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

SABSW Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Sab Biotherapeutics, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.0126 and $0.0135. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, July 07, 2026, and so far it has fallen -27.38%. Further fall is indicated until a new bottom pivot has been found. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may not be. The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for Sab Biotherapeutics, Inc. stock

Sab Biotherapeutics, Inc. finds support from accumulated volume at $0.0120 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.0358 between high and low, or 300.84%. For the last week the stock has had daily average volatility of 236.77%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (SABSW) For The Upcoming Trading Day Of Monday 13th

For the upcoming trading day on Monday, 13th we expect Sab Biotherapeutics, Inc. to open at $0.0239, and during the day (based on 14 day Average True Range), to move between $0.0038 and $0.0206, which gives a possible trading interval of +/-$0.0169 (+/-446.77%) up or down from last closing price. If Sab Biotherapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 446.77% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.0124 (1.64%) than the support at $0.0120 (1.64%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Sab Biotherapeutics, Inc. stock A Buy?

Sab Biotherapeutics, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -5.748 Strong Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 13, 2026 - $0.0239 ( 96.17%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk